PARIS, France (AFP) — US pharmaceutical firm Moderna said Thursday it expects to increase global production of its cutting-edge Covid vaccine to up to three billion doses in 2022. The company said in a statement that it would make new funding commitments to increase supply at its manufacturing facilities in Europe and the United States. The investments will double the manufacturing of drug substance at its Swiss partner Lonza and more than double output by […]